Trends of Renal Biopsy in Pediatric Patients at Tanta University Hospital for 10 Years From 2012 to 2022.

August 2, 2024 updated by: Sara Mabrouk Elghoul, Tanta University

Trends of Renal Biopsy in Pediatric Patients at Tanta University Hospital

This study will be conducted on pediatric patients less than 18 years' old who underwent renal biopsy at Tanta University Hospital from 2012 to 2022.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

This study will be conducted on pediatric patients less than 18 years' old who underwent renal biopsy at Tanta University Hospital from 2012 to 2022.

The data will be collected from records:

  1. History taking including age and sex.
  2. Indications for renal biopsy.
  3. Methods of renal biopsy
  4. Complications of renal biopsy
  5. Adequacy of samples
  6. The results obtained by light microscopy
  7. The results obtained by electron microscopy, immunofluorescence when indicated

Study Type

Observational

Enrollment (Estimated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tanta, Qism 1
      • Tanta, Tanta, Qism 1, Egypt, 31511
        • Sara Mabrouk Mohamed Elghoul

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All pediatric patients less than 18 years' old who underwent renal biopsy.

Description

Inclusion Criteria:

  • All pediatric patients less than 18 years' old who underwent renal biopsy.

Exclusion Criteria:

  • no exclusions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
pediatric patients less than 18 years' old who underwent renal biopsy
pediatric patients less than 18 years' old who underwent renal biopsy at Tanta University Hospital from 2012 to 2022.
percutaneous renal biopsy procedure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the indications of renal biopsy
Time Frame: 3 months
investigate the indications of renal biopsy in pediatric patients at Tanta University Hospital for 10 years from 2012 to 2022
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
light , electron microscope and immunofluorescence results of renal biopsy
Time Frame: 3 months
investigate the results of renal biopsy in pediatric patients at Tanta University Hospital for 10 years from 2012 to 2022
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sara Mabrouk Mohamed Elghoul, MD, Tanta University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 28, 2023

Primary Completion (Estimated)

September 1, 2024

Study Completion (Estimated)

September 1, 2024

Study Registration Dates

First Submitted

July 30, 2024

First Submitted That Met QC Criteria

July 30, 2024

First Posted (Actual)

August 1, 2024

Study Record Updates

Last Update Posted (Actual)

August 6, 2024

Last Update Submitted That Met QC Criteria

August 2, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Renal Diseases

Clinical Trials on renal biopsy

Subscribe